MarketBeat Instant News Alerts 2 hours agoXenon Pharmaceuticals (NASDAQ:XENE) Price Target Cut to $70.00 by Analysts at Royal Bank Of CanadaMarketBeatRoyal Bank Of Canada reduced their price target on shares of Xenon Pharmaceuticals from $81.00 to $70.00 and set an "outperform" rating on the stock in a research report on Friday.NASDAQ:XENERead Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Cut to $70.00 by Analysts at Royal Bank Of Canada2 hours agoCrane NXT (NYSE:CXT) Given Buy Rating at DA DavidsonMarketBeatDA Davidson reiterated a "buy" rating and issued a $85.00 price objective on shares of Crane NXT in a research report on Friday.NYSE:CXTRead Crane NXT (NYSE:CXT) Given Buy Rating at DA Davidson2 hours agoEVI Industries (NYSEAMERICAN:EVI) Given Buy Rating at DA DavidsonMarketBeatDA Davidson restated a "buy" rating and set a $32.00 price objective on shares of EVI Industries in a research report on Friday.NYSEAMERICAN:EVIRead EVI Industries (NYSEAMERICAN:EVI) Given Buy Rating at DA Davidson2 hours agoLeerink Partners Reaffirms Outperform Rating for Ardent Health (NYSE:ARDT)MarketBeatLeerink Partners restated an "outperform" rating and set a $14.00 price objective on shares of Ardent Health in a report on Friday.NYSE:ARDTRead Leerink Partners Reaffirms Outperform Rating for Ardent Health (NYSE:ARDT)2 hours agoHCA Healthcare (NYSE:HCA) Given "Outperform" Rating at Leerink PartnersMarketBeatLeerink Partners reissued an "outperform" rating and set a $492.00 target price on shares of HCA Healthcare in a research note on Friday.NYSE:HCARead HCA Healthcare (NYSE:HCA) Given "Outperform" Rating at Leerink Partners2 hours agoTenet Healthcare (NYSE:THC) Given "Outperform" Rating at Leerink PartnersMarketBeatLeerink Partners restated an "outperform" rating and issued a $309.00 price objective on shares of Tenet Healthcare in a research note on Friday.NYSE:THCRead Tenet Healthcare (NYSE:THC) Given "Outperform" Rating at Leerink Partners Trending News1Rivian Automotive (NASDAQ:RIVN) Insider Sells $244,350.00 in Stock2Nykredit A S Purchases Shares of 1,480,345 Netflix, Inc. $NFLX3Fannie Mae (OTCMKTS:FNMA) Shares Down 7.4% - Here's Why4Nicola Loporcaro Sells 1,457,102 Shares of GMR Solutions (NYSE:GMRS) Stock5Advanced Micro Devices (NASDAQ:AMD) CEO Lisa Su Sells 70,000 Shares of Stock6Reddit (NYSE:RDDT) COO Jennifer Wong Sells 60,000 Shares of Stock7QuantumScape Ramps Pilot Line as Solid-State Battery Markets Expand8Citigroup Issues Pessimistic Forecast for NIKE (NYSE:NKE) Stock Price All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Recommendation of "Moderate Buy" by BrokeragesMarketBeatNASDAQ:LENZRead LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Recommendation of "Moderate Buy" by Brokerages2 hours agoFour Corners Property Trust, Inc. (NYSE:FCPT) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarketBeatNYSE:FCPTRead Four Corners Property Trust, Inc. (NYSE:FCPT) Receives Consensus Recommendation of "Moderate Buy" from Analysts2 hours agoGlobalstar, Inc. (NASDAQ:GSAT) Receives Consensus Recommendation of "Hold" from AnalystsMarketBeatNASDAQ:GSATRead Globalstar, Inc. (NASDAQ:GSAT) Receives Consensus Recommendation of "Hold" from Analysts2 hours agoAdicet Bio, Inc. (NASDAQ:ACET) Receives Average Recommendation of "Moderate Buy" from AnalystsMarketBeatNASDAQ:ACETRead Adicet Bio, Inc. (NASDAQ:ACET) Receives Average Recommendation of "Moderate Buy" from Analysts2 hours agoCardiff Oncology, Inc. (NASDAQ:CRDF) Given Average Recommendation of "Hold" by AnalystsMarketBeatNASDAQ:CRDFRead Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Average Recommendation of "Hold" by Analysts2 hours agoAlkami Technology, Inc. (NASDAQ:ALKT) Receives Average Rating of "Hold" from AnalystsMarketBeatNASDAQ:ALKTRead Alkami Technology, Inc. (NASDAQ:ALKT) Receives Average Rating of "Hold" from Analysts2 hours agoNova Ltd. (NASDAQ:NVMI) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMarketBeatNASDAQ:NVMIRead Nova Ltd. (NASDAQ:NVMI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages2 hours agoLa-Z-Boy Incorporated (NYSE:LZB) Given Consensus Rating of "Hold" by AnalystsMarketBeatNYSE:LZBRead La-Z-Boy Incorporated (NYSE:LZB) Given Consensus Rating of "Hold" by Analysts2 hours agoCeriBell, Inc. (NASDAQ:CBLL) Receives Average Recommendation of "Moderate Buy" from BrokeragesMarketBeatNASDAQ:CBLLRead CeriBell, Inc. (NASDAQ:CBLL) Receives Average Recommendation of "Moderate Buy" from Brokerages2 hours agoPerrigo Company plc (NYSE:PRGO) Receives Consensus Rating of "Hold" from AnalystsMarketBeatNYSE:PRGORead Perrigo Company plc (NYSE:PRGO) Receives Consensus Rating of "Hold" from Analysts2 hours agoEvolus, Inc. (NASDAQ:EOLS) Receives Average Recommendation of "Moderate Buy" from AnalystsMarketBeatNASDAQ:EOLSRead Evolus, Inc. (NASDAQ:EOLS) Receives Average Recommendation of "Moderate Buy" from Analysts2 hours agoBBB Foods Inc. (NYSE:TBBB) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarketBeatNYSE:TBBBRead BBB Foods Inc. (NYSE:TBBB) Receives Consensus Recommendation of "Moderate Buy" from Analysts2 hours agoJames River Group Holdings, Ltd. (NASDAQ:JRVR) Given Consensus Rating of "Reduce" by BrokeragesMarketBeatNASDAQ:JRVRRead James River Group Holdings, Ltd. (NASDAQ:JRVR) Given Consensus Rating of "Reduce" by Brokerages2 hours agoLKQ Corporation (NASDAQ:LKQ) Given Consensus Rating of "Hold" by AnalystsMarketBeatNASDAQ:LKQRead LKQ Corporation (NASDAQ:LKQ) Given Consensus Rating of "Hold" by Analysts2 hours agoSouthwest Gas Corporation (NYSE:SWX) Receives Average Recommendation of "Moderate Buy" from BrokeragesMarketBeatNYSE:SWXRead Southwest Gas Corporation (NYSE:SWX) Receives Average Recommendation of "Moderate Buy" from Brokerages2 hours agoEastern Bankshares, Inc. (NASDAQ:EBC) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMarketBeatNASDAQ:EBCRead Eastern Bankshares, Inc. (NASDAQ:EBC) Given Consensus Recommendation of "Moderate Buy" by Brokerages2 hours agoKORU Medical Systems, Inc. (NASDAQ:KRMD) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarketBeatNASDAQ:KRMDRead KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Consensus Recommendation of "Moderate Buy" by Analysts2 hours agoAmdocs Limited (NASDAQ:DOX) Receives Average Rating of "Hold" from AnalystsMarketBeatNASDAQ:DOXRead Amdocs Limited (NASDAQ:DOX) Receives Average Rating of "Hold" from Analysts2 hours agoMGIC Investment Corporation (NYSE:MTG) Given Consensus Rating of "Moderate Buy" by AnalystsMarketBeatNYSE:MTGRead MGIC Investment Corporation (NYSE:MTG) Given Consensus Rating of "Moderate Buy" by Analysts2 hours agoOrion Group Holdings, Inc. (NYSE:ORN) Receives Average Rating of "Moderate Buy" from BrokeragesMarketBeatNYSE:ORNRead Orion Group Holdings, Inc. (NYSE:ORN) Receives Average Rating of "Moderate Buy" from Brokerages2 hours agoChartwell Retirement Residences (TSE:CSH.UN) Receives Consensus Rating of "Buy" from BrokeragesMarketBeatTSE:CSH.UNRead Chartwell Retirement Residences (TSE:CSH.UN) Receives Consensus Rating of "Buy" from Brokerages2 hours agoElicio Therapeutics, Inc. (NASDAQ:ELTX) Receives Average Recommendation of "Moderate Buy" from BrokeragesMarketBeatNASDAQ:ELTXRead Elicio Therapeutics, Inc. (NASDAQ:ELTX) Receives Average Recommendation of "Moderate Buy" from Brokerages2 hours agoFirst Western Financial (NASDAQ:MYFW) Coverage Initiated at Hovde GroupMarketBeatNASDAQ:MYFWRead First Western Financial (NASDAQ:MYFW) Coverage Initiated at Hovde Group2 hours agoNovoCure Eyes Glioblastoma Growth, Cancer Launches and EBITDA Break-EvenMarketBeatNASDAQ:NVCRRead NovoCure Eyes Glioblastoma Growth, Cancer Launches and EBITDA Break-Even Featured Articles and Offers3 Luxury Consumer Brands to Watch in a Beaten-Down SectorBy Nathan Reiff | September 16, 2026Is This the New Normal for Gold?From Wall Street Logic (Ad)Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed EarningsBy Dan Schmidt | September 14, 2026Why Bitcoin ETFs May Be Worth Another Look as Inflows ReboundBy Nathan Reiff | September 13, 2026Running on Empty: 3 Energy Plays for Europe's Deep FreezeBy Jeffrey Neal Johnson | September 15, 2026$0. Later: $29.97.From Profits Run (Ad)Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?By Ryan Hasson | September 12, 20263 Dividend Kings to Buy While They’re Still Beaten DownBy Thomas Hughes | September 14, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 266 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
